Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...